Ben Salah N, Amamou M, et al. 1986. A case of overdose with Peganum harmala L. J Toxicol Clin Exp, 6: 319-322.
Chen Q, Chao R, et al. 2005. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer, 114: 675-682.
el Bahri L and Chemli R. 1991. Peganum harmala L: a poisonous plant of North Africa. Vet Hum Toxicol, 33: 276-277.
Frison G, Favretto D, et al. 2008. A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Sci Int, 179: e37-43.
Herraiz T, Gonzalez D, et al. 2010. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol, 48: 839-845.
Jahaniani F, Ebrahimi SA, et al. 2005. Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent. Phytochemistry, 66: 1581-1592.
Mahmoudian M, Jalilpour H, et al. 2002 Toxicity of Peganum harmala: Review and a Case Report. Iran J Pharmaco Therap, 1: 1-4.
Marwat SK, Rehman Fu, et al. 2011. Chapter 70 - Medicinal and Pharmacological Potential of Harmala (Peganum harmala L.) Seeds. Nuts and Seeds in Health and Disease Prevention. San Diego, Academic Press: 585-599.
Pranzatelli MR and Snodgrass SR. 1987. Harmala alkaloids and related beta-carbolines: a myoclonic model and antimyoclonic drugs. Exp Neurol, 96: 703-719.
Puzii AD, Vecherkin SS, et al. 1980. Toxicity of the total alkaloids of the harmal. Veterinariia: 57-58.
Shi CC, Chen SY, et al. 2000. Vasorelaxant effect of harman. Eur J Pharmacol, 390: 319-325.
Yuruktumen A, Karaduman S, et al. 2008. Syrian rue tea: a recipe for disaster. Clin Toxicol (Phila), 46: 749-752.